TABLE 2.
Toxicity of MG.
| Activity | Cell lines | Dosage | Application | References |
|---|---|---|---|---|
| Inhibition of cell viability | U937 and LO-2 cells | 10–100 μM | In vitro | Chen H et al. (2019) |
| Inhibition of cell viability | MMECs | 50–200 μg ml−1 | In vitro | Wei et al. (2014) |
| Inhibition of cell migration | VSMCs | 40 μM | In vitro | Karki et al. (2013a) |
| Inhibition of cell viability | Murine 3T3-F442A predipocytes and human normal subcutaneous predipocytes | 30–100 μM | In vitro | Alonso-Castro et al. (2011) |
| Inhibition of cell growth | mES-derived endothelial-like cells | 50–100 μM | In vitro | Kim GD et al. (2013) |
| Inhibition of cell viability | MCF-10A, MCF-7, SK-BR3, MDA-MB-453, MDA-MB-435S, MDA-MB-231, and MDA-MB-468 cells | IC50: 70.52 ± 5.09, 36.46 ± 2.38, 59.40 ± 8.24, 35.69 ± 4.91, 25.39 ± 3.26, 25.32 ± 2.72, and 24.79 ± 3.06 μM, respectively | In vitro | Liu et al. (2013) |
| Inhibition of cell viability | HCT-116 cells | 1–50 μM | In vitro | Park et al. (2012) |
| Inhibition of cell viability | OC2 cells | 20–100 μM | In vitro | Hsieh et al. (2018) |
| Inhibition of cell viability | A549 cells | 6.25–200 μM | In vitro | Wu et al. (2014) |
| Inhibition of cell viability | DU145 and PC3 cells | 40 and 80 μM | In vitro | McKeown et al. (2014) |
| Induction of cell apoptosis | GBC cells | 10–30 μM | In vitro | Li et al. (2015) |
| Induction of cell apoptosis | SGC-7901 cells | 10–300 μM | In vitro | Rasul et al. (2012) |
| Inhibition of cell proliferation | SKOV3 and TOV21G cells | 6.25–100 μM | In vitro | Chuang et al. (2011) |
| Inhibition of cell proliferation | QBC939, SK-ChA-1, MZ-ChA-1, and RBE cells | 20–160 μM | In vitro | Zhang FH et al. (2017) |